TG THERAPEUTICS, INC. (TGTX) Gross margin 2021–2025
TG THERAPEUTICS, INC. (TGTX) gross margin by fiscal year — reported gross profit divided by reported revenue.
83.7%FY2025 · since FY2021: 88.2% → 83.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 83.7% | -4.6 pp |
| FY2024 | 88.3% | -5.7 pp |
| FY2023 | 94.0% | +3.5 pp |
| FY2022 | 90.5% | +2.3 pp |
| FY2021 | 88.2% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More TGTX financial trends
TGTX RevenueTGTX Net incomeTGTX Net marginTGTX Gross profitTGTX Operating incomeTGTX Operating marginTGTX Operating cash flowTGTX Free cash flowTGTX Capital expendituresTGTX Return on equityTGTX Stock buybacksTGTX Dividends paidTGTX Total assetsTGTX Total liabilitiesTGTX Shareholders’ equityTGTX overview →